Established in Singapore, Enleofen is a MedTech startup which aims to have its lead antibody in clinical trials within 2years. Currently, Enleofen is developing a drug that can be used to trate mutilple diseases which therefre are no treatment option nowadays.
| Company Name | Enleofen Bio Pte Ltd |
|---|---|
| Brand Name | Enleofen Bio Pte Ltd |
| Industries | Healthcare |
| Year of Establishment | 2017 |
| Founder(s) | Stuart Cook Sebastian Sch? §fer |
| No. of Employees | / |
| Regional Coverage | Singapore |
| Clients | / |
| Stage | Series A |
| Investor(s) | Goodman Capital |
| Fundraising History | Undisclosed amount (Apr 2017) |
| Raising Fund | / |
| Fundraising target | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Media Exposure | nature reviews Business Wire The Straits Times TODAYonline |
| Company Email | info@enleofen.com |
[dcb id=160440]